跳至主要内容
临床试验/NCT04400916
NCT04400916Unknown不适用

Topical Use of Tranexamic Acid for Prevention of Subconjunctival Hemorrhage After Intravitreal Injections

Rambam Health Care Campus0 个研究点目标入组 100 人开始时间: 2020年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
100
主要终点
Subconjunctival hemorrahge

研究概览

简要总结

We aim to investigate whether topical administration of Tranexamic acid can reduce the occurence of subconjunctival hemorrahge after routine intravitreal injections for retinal conditions.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects receiving intravitreal injections as part of their routine ophthalmological care

排除标准

  • Pregnancy, Oral contraceptives/HRT use, Known systemic autoimmune disease, Renal failure, active/suspected infection or inflammation in the treated eye, subconjunctival hemorrahge prior to inclusion, History of subarachnoid hemorrahge, thromboembolic events, increased risk for thromboembolic events, known sensitivity to the study drug

研究组 & 干预措施

Topical tranexamic acid

Experimental

干预措施: Tranexamic acid (Drug)

Topical BSS

Placebo Comparator

干预措施: Balanced Salt Solution (Other)

结局指标

主要结局

Subconjunctival hemorrahge

时间窗: 3 days

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shiri Soudry MD

Attending faculty and vitreoretinal surgeon, Department of Ophthalmology

Rambam Health Care Campus

相似试验